Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 1582 | 2020 |
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016 | 1104 | 2016 |
Bile acids: chemistry, physiology, and pathophysiology MJ Monte, JJG Marin, A Antelo, J Vazquez-Tato World journal of gastroenterology: WJG 15 (7), 804, 2009 | 667 | 2009 |
The antiviral activities of artemisinin and artesunate T Efferth, MR Romero, DG Wolf, T Stamminger, JJG Marin, M Marschall Clinical infectious diseases 47 (6), 804-811, 2008 | 581 | 2008 |
Expression of members of the multidrug resistance protein family in human term placenta MV St-Pierre, MA Serrano, RIR Macias, U Dubs, M Hoechli, U Lauper, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2000 | 454 | 2000 |
Wnt–β-catenin signalling in liver development, health and disease MJ Perugorria, P Olaizola, I Labiano, A Esparza-Baquer, M Marzioni, ... Nature reviews Gastroenterology & hepatology 16 (2), 121-136, 2019 | 436 | 2019 |
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system MR Romero, T Efferth, MA Serrano, B Castaño, RIR Macias, O Briz, ... Antiviral research 68 (2), 75-83, 2005 | 325 | 2005 |
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma A Arbelaiz, M Azkargorta, M Krawczyk, A Santos‐Laso, A Lapitz, ... Hepatology 66 (4), 1125-1143, 2017 | 276 | 2017 |
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice I Uriarte, MG Fernandez-Barrena, MJ Monte, MU Latasa, HCY Chang, ... Gut 62 (6), 899-910, 2013 | 209 | 2013 |
Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin O Briz, MA Serrano, RIR MacIas, J Gonzalez-Gallego, JJG Marin Biochemical Journal 371 (3), 897-905, 2003 | 209 | 2003 |
Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta MA Serrano, D Brites, MG Larena, MJ Monte, MP Bravo, N Oliveira, ... Journal of hepatology 28 (5), 829-839, 1998 | 206 | 1998 |
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 204 | 2019 |
Bile acids in physiology, pathology and pharmacology J JG Marin, R IR Macias, O Briz, J M Banales, M J Monte Current drug metabolism 17 (1), 4-29, 2016 | 189 | 2016 |
Carriers involved in targeting the cytostatic bile acid-cisplatin derivativescis-diammine-chloro-cholylglycinate-platinum (II) andcis-Diammine-bisursodeoxycholate-platinum (II … O Briz, MA Serrano, N Rebollo, B Hagenbuch, PJ Meier, H Koepsell, ... Molecular pharmacology 61 (4), 853-860, 2002 | 189 | 2002 |
Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy M Vallejo, O Briz, MA Serrano, MJ Monte, JJG Marin Journal of hepatology 44 (6), 1150-1157, 2006 | 181 | 2006 |
Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV) MR Romero, MA Serrano, M Vallejo, T Efferth, M Alvarez, JJG Marin Planta medica 72 (13), 1169-1174, 2006 | 178 | 2006 |
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature Reviews Gastroenterology & Hepatology 13 (5), 261-280, 2016 | 175 | 2016 |
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry L Izquierdo-Sanchez, A Lamarca, A La Casta, S Buettner, K Utpatel, ... Journal of hepatology 76 (5), 1109-1121, 2022 | 165 | 2022 |
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib E Herraez, E Lozano, RIR Macias, J Vaquero, L Bujanda, JM Banales, ... Hepatology 58 (3), 1065-1073, 2013 | 165 | 2013 |
Mechanisms of resistance to chemotherapy in gastric cancer JJG Marin, R Al-Abdulla, E Lozano, O Briz, L Bujanda, J M Banales, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 151 | 2016 |